wang, L. 2025. Clinical Progress of Targeted KRAS Drugs Combined with Immune Checkpoint Inhibitors in the Treatment of Pancreatic Cancer. Transactions on Materials, Biotechnology and Life Sciences. 8, (Oct. 2025), 397–402. DOI:https://doi.org/10.62051/rq7x6r98.